申请人:Osaka University
公开号:EP2567956A1
公开(公告)日:2013-03-13
A compound represented by the general formula (C):
(wherein R101 represents a substituted or unsubstituted aromatic heterocyclic group,
R102, R103, R104 and R105 may be the same or different, and each represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 3 carbon atoms, or a haloalkyl group having 1 to 3 carbon atoms, and
R106 represents a hydrogen atom, or a saturated or unsaturated hydrocarbon group which is a straight or branched chain having 1 to 12 carbon atoms, but
excluded is the case where R101 is a 3-furyl group, R102, R103, R104 and R105 are all methyl groups, and R106 is a methyl group, a 4-methyl-3-pentenyl group or a 4,8-dimethyl-3,7-nonadienyl group); or
a pharmaceutically acceptable salt thereof has selective inhibitory activity on hypoxic cell growth in a broad range of the concentration and therefore is useful as an active ingredient of a medicament for cancer prevention or treatment.
通式(C)代表的化合物:
(其中 R101 代表取代或未取代的芳香杂环基团、
R102、R103、R104 和 R105 可以相同或不同,各自代表氢原子、卤素原子、具有 1 至 3 个碳原子的烷基或具有 1 至 3 个碳原子的卤代烷基,以及
R106 代表氢原子,或具有 1 至 12 个碳原子的直链或支链的饱和或不饱和烃基,但
R101为3-呋喃基,R102、R103、R104和R105均为甲基,R106为甲基、4-甲基-3-戊烯基或4,8-二甲基-3,7-壬二烯基)的情况除外;或
其药学上可接受的盐在较宽的浓度范围内对缺氧细胞生长具有选择性抑制活性,因此可用作预防或治疗癌症药物的活性成分。